Corcept Therapeutics
CORT
#2078
Rank
โ‚ฌ7.79 B
Marketcap
73,96ย โ‚ฌ
Share price
1.71%
Change (1 day)
28.56%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ5.46 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is โ‚ฌ5.46 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ6.66 M4779.61%
2023-12-31โ‚ฌ0.13 M-87.18%
2022-12-31โ‚ฌ1.06 M129.42%
2021-12-31โ‚ฌ0.46 M-77.61%
2020-12-31โ‚ฌ2.07 M-32.87%
2019-12-31โ‚ฌ3.08 M
2018-12-31N/A
2016-12-31โ‚ฌ13.94 M1.86%
2015-12-31โ‚ฌ13.68 M76.63%
2014-12-31โ‚ฌ7.74 M86.33%
2013-12-31โ‚ฌ4.15 M107.58%
2012-12-31โ‚ฌ2 M
2010-12-31N/A-100%
2009-12-31โ‚ฌ0 M-63.41%
2008-12-31โ‚ฌ0.01 M-42.38%
2007-12-31โ‚ฌ0.01 M-37.6%
2006-12-31โ‚ฌ0.03 M-30.17%
2005-12-31โ‚ฌ0.04 M
2003-12-31โ‚ฌ0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.50 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ36.50 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ35.53 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.26 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.10 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.51 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA